TRANSCRIPTOME ANALYSIS OF IMMUNITY RELATED GENES AS EARLY PREDICTOR OF GRAFT VERSUS HOST DISEASE.

被引：0
|
作者：
Dharmani-Khan, Poonam [1 ]
Faridi, Rehan M. [1 ]
Akhter, Ariz [1 ]
Berka, Noureddine [1 ]
Storek, Jan [1 ]
Khan, Faisal M. [2 ]
机构：
[1] Univ Calgary, Med, Calgary, AB, Canada
[2] Univ Calgary, Pathol & Lab Med, Calgary, AB, Canada
来源：
HUMAN IMMUNOLOGY | 2016年 / 77卷
关键词：
D O I：
10.1016/j.humimm.2016.07.060
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OR41
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] Transcriptome Analysis of Immune-function Genes as Early Predictor of Graft-versus-Host Disease
    Dharmani-Khan, P.
    Faridi, R. M.
    Akhter, A.
    Storek, J.
    Khan, F. M.
    TRANSFUSION, 2016, 56 : 4A - 4A
  • [2] Early detection of acute graft versus host disease by assessment of the immunity related transcriptome
    Kalra, A.
    Hebert, J.
    Faridi, R.
    Dharmani-Khan, P.
    Shabani-Rad, M.
    Lewis, V.
    Storek, J.
    Khan, F.
    HUMAN IMMUNOLOGY, 2024, 85 : 38 - 39
  • [3] Differential Expression of Immunity Related Genes and Early Prediction of Severe Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation
    Dharmani-Khan, Poonam
    Faridi, Rehan Mujeeb
    Akhter, Ariz
    Kalra, Amit
    Storek, Jan
    Khan, Faisal M.
    BLOOD, 2016, 128 (22)
  • [4] Ocular graft-versus-host disease.
    Heffler, KF
    Grossman, H
    Marks, D
    Topolsky, D
    Styler, M
    Moul, J
    Crilley, P
    Brodsky, I
    BLOOD, 1995, 86 (10) : 3784 - 3784
  • [5] Ocular graft versus host disease. Corneal complications
    Westekemper, H.
    Scholz, S. L.
    Thomasen, H.
    Halfwassen, C.
    Steuhl, K-P
    OPHTHALMOLOGE, 2017, 114 (08): : 697 - 702
  • [6] Infliximab for the treatment of chronic graft versus host disease.
    Tolbert, Ethan
    Waller, Ned
    Khoury, H. Jean
    Lechowicz, Mary Jo
    Flowers, Christopher
    Lonial, Sagar
    Vann, Laura
    Langston, Amelia
    Kaufman, Jonathan L.
    BLOOD, 2006, 108 (11) : 818A - 818A
  • [7] Association between regimen related toxicity and acute-graft-versus-host disease.
    Copelan, EA
    Penza, S
    Lin, T
    Blum, W
    Farag, S
    Elder, P
    Avalos, B
    BLOOD, 2004, 104 (11) : 337B - 337B
  • [8] NATURAL IMMUNITY AND GRAFT-VERSUS-HOST DISEASE
    GRATAMA, JW
    LIPOVICHOOSTERVEER, MA
    RONTELTAP, C
    SINNIGE, LGF
    JANSEN, J
    VANDERGRIEND, RJ
    BOLHUIS, RLH
    TRANSPLANTATION, 1985, 40 (03) : 256 - 260
  • [9] Hydroxychloroquine for the treatment of chronic graft-versus-host disease.
    Gilman, A
    Morris, C
    Mogul, M
    Mazumder, A
    Lee, CK
    Gingrich, R
    Goldman, F
    Trigg, M
    BLOOD, 1996, 88 (10) : 2421 - 2421
  • [10] Primary treatment inconsistencies in chronic graft versus host disease.
    Bensen-Kennedy, DM
    Hallick, J
    Jacobsohn, DA
    Anders, V
    Vogelsang, GB
    BLOOD, 2002, 100 (11) : 847A - 847A
12345